First successful outcomes of pegvaliase (PALYNZIQ) in children.

Published in: BMC medical genomics (2024)

This report addresses the potential broader applications of Pegvaliase in children, as well as its safety and tolerability in this age group. However, larger sample sizes and robust methodologies are required to validate such findings.

Keyphrases

young adults
open label
clinical trial
type diabetes
risk assessment
skeletal muscle
human health
climate change
insulin resistance
study protocol
glycemic control